Clinical Trial Detail

NCT ID NCT02576665
Title A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Subjects With Solid Tumors (Toca6)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Tocagen Inc.
Indications

non-small cell lung carcinoma

renal cell carcinoma

pancreatic cancer

Advanced Solid Tumor

breast cancer

colorectal cancer

melanoma

Therapies

Toca 511 + Toca FC

Age Groups: adult senior

No variant requirements are available.